Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis: A Systematic Review and Meta-analysis

• Results Overview

  Topical PDE4 inhibitors (particularly crisaborole and AN2898) were found to be safe and effective treatments for mild to moderate eczema, showing significant improvement in skin symptoms compared to vehicle (placebo) treatment.

• Study Summary

  Num Participants:

  1,869

  Study Type:

  Review

  Control Group:

  Topical Vehicle (Placebo)

  Efficacy End Points Treatment:

  None

  Efficacy End Points Control:

  None

  Side Effects Treatment:

  Adverse Event	Severity	Percentage Affected

  Side Effects Control:

  Adverse Event	Severity	Percentage Affected